Wednesday, December 10, 2014

Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer.

This study found that both aspirin and COX-2 inhibitors were associated with improved outcomes in stage III colon cancer patients.  (J Natl Cancer Inst. 2014 Nov 27;107(1). pii: dju345. Print 2015 Jan.)
Read More